Renaissance Capital logo

MCFE News

US IPO Week Ahead: 7 IPOs squeeze in before the Thanksgiving holiday

MRVI

Updated Monday, 11/16. US IPO market activity is picking back up ahead of the Thanksgiving holiday, with seven IPOs scheduled to raise $3.6 billion in the week ahead.  Biotech research product provider Maravai LifeSciences (MRVI) plans to raise $1.3 billion at a $6.6 billion market cap. Maravai provides critical products to enable...read more

US IPO Weekly Recap: McAfee leads a 5 IPO week

MCFE

Five IPOs and 17 SPACs went public this past week. While new filing activity has slowed as the election approaches, four IPOs and four SPACs submitted initial filings. Leading security software provider McAfee (MCFE) priced slightly below the midpoint to raise $740 million at a $9.4 billion market cap. Taken private by Intel in 2011, McAfee provides...read more

McAfee prices IPO at $20, within the range

MCFE

McAfee, a leading provider of antivirus and endpoint security software, raised $740 million by offering 37 million shares at $20, within the range of $19 to $22. McAfee plans to list on the Nasdaq under the symbol MCFE. Morgan Stanley, Goldman Sachs, TPG Capital BD, BofA Securities, Citi, RBC Capital Markets, Deutsche Bank, UBS Investment Bank, HSBC and Mizuho Securities acted as...read more

US IPO Week Ahead: McAfee returns to the public market in a 5 IPO week

MCFE

Updated Monday, 10/19. Five IPOs and two SPACs are expected to raise $2.1 billion in the week ahead, led by leading cybersecurity brand McAfee (MCFE). Taken private by Intel in 2011, McAfee (MCFE) plans to raise $759 million at a $9.6 billion market cap in its return to the public market. McAfee provides integrated security...read more